The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
Open accessAbstract
Background and aims: A subgroup of colorectal cancers (CRC) referred to as the CpG island methylator phenotype (CIMP+) shows simultaneous methylation of multiple CpG islands. The clinicopathological and molecular characteristics of this phenotype remain uncertain however. Methods: We analysed methylation of CpG islands in the p16 and MDR1 genes and MINT-2 clone in 275 stage II/III CRCs. Results: Concurrent methylation of two or more CpG islands was observed in 32% of cases and was considered to represent CIMP+. These were often poorly differentiated, had less TP53 mutations, and originated frequently in the proximal or higher stage CRC compared with CIMP− tumours (p<0.05 for each). CIMP+ had no prognostic significance in stage II or stage III CRC treated by surgery alone. hMLH1 methylated tumours comprised the majority (81%) of cases with microsatellite instability, were frequently observed in older female patients, were often poorly differentiated or CIMP+, and contained wild-type K- ras (p<0.05 for each). Females who were heterozygous or homozygous for the C677T MTHFR polymorphism were at increased risk of developing CIMP+ CRC (odds ratio 2.17, 95% confidence interval 1.03–4.57; p=0.037). Conclusions: These observations made in a relatively large unselected series of CRC support the notion that CIMP+ characterises a subgroup of tumours with distinctive phenotypic features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,928
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-5-199503010-00001 · Cited by 925
Ma, J., Stampfer, M. J., Giovannucci, E. L., Artigas, C., Hunter, D. J., Fuchs, C. S., Willett, W. C., Selhub, J., Hennekens, C. H., & Rozen, R. R. (1997) · PubMed · Cited by 774
Gonzalez‐Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T. T., Beart, R. W., Tornout, J. M. V., & Jones, P. A. (1995) · PubMed · Cited by 772
Bufill, J. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-10-779 · Cited by 722
Aging and DNA methylation in colorectal mucosa and cancer.
Ahuja, N., Li, Q., MOHAN, A. L., Baylin, S. B., & Issa, J. J. (1998) · PubMed · Cited by 618
Elsaleh, H., Joseph, D., Grieu, F., Zeps, N., Spry, N., & Iacopetta, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02261-3 · Cited by 552
Self-citationEsteller, M., Tórtola, S., Toyota, M., Capellá, G., Peinado, M. A., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 531
A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer.
Chen, J., Giovannucci, E. L., Kelsey, K. T., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Spiegelman, D. L., Willett, W. C., & Hunter, D. J. (1996) · PubMed · Cited by 516
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
Toyota, M., Ohe-Toyota, M., Ahuja, N., & Issa, J.-P. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.710 · Cited by 473
Hypermethylation of multiple genes in pancreatic adenocarcinoma.
Ueki, T., Toyota, M., Sohn, T. A., Yeo, C. J., Issa, J. J., Hruban, R. H., & Goggins, M. (2000) · PubMed · Cited by 407
Methylenetetrahydrofolate reductase, diet, and risk of colon cancer.
Slattery, M. L., Potter, J. D., Samowitz, W. S., Schaffer, D., & Leppert, M. (1999) · PubMed · Cited by 395
Hawkins, N. J., & Ward, R. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1307 · Cited by 334
Association between CpG island methylation and microsatellite instability in colorectal cancer.
Ahuja, N., MOHAN, A. L., Li, Q., Stolker, J. M., Herman, J. G., Hamilton, S. R., Baylin, S. B., & Issa, J. J. (1997) · PubMed · Cited by 295
Kuismanen, S. A., Holmberg, M. T., Salovaara, R., de la Chapelle, A., & Peltomäki, P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65048-1 · Cited by 288
Zhou, X.-P., Hoang, J.-M., Li, Y.-J., Seruca, R., Carneiro, F., Sobrinho-Simoes, M., Lothe, R. A., Gleeson, C. M., Russell, S. E. H., Muzeau, F., et al. (1998) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199802)21:2<101::aid-gcc4>3.0.co;2-4 · Cited by 238
Slattery, M. L., Potter, J. D., Curtin, K., Edwards, S. L., Ma, K. N., Anderson, K. E., Schaffer, D., & Samowitz, W. S. (2001) · PubMed · Cited by 237
K-ras and p16 Aberrations Confer Poor Prognosis in Human Colorectal Cancer
Esteller, M., González, S., Risques, R. A., Marcuello, E., Mangues, R., Germà, J. R., Herman, J. G., Capellà, G., & Peinado, M. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.299 · Cited by 234
Different mechanisms in the tumorigenesis of proximal and distal colon cancers
Lindblom, A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200101000-00013 · Cited by 212
Elsaleh, H., Powell, B. L., McCaul, K. A., Grieu, F., Grant, R., Joseph, D., & Iacopetta, B. J. (2001) · PubMed · Cited by 204
Self-citationAberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
Toyota, M., Shen, L., Ohe-Toyota, M., Hamilton, S. R., Sinicrope, F. A., & Issa, J. J. (2000) · PubMed · Cited by 191
Methylation Silencing and Mutations of the p14ARF and p16INK4a Genes in Colon Cancer
Burri, N., Shaw, P., Bouzourene, H., Sordat, I., Sordat, B., Gillet, M., Schorderet, D., Bosman, F. T., & Chaubert, P. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780230 · Cited by 181
Breivik, J., Lothe, R. A., Meling, G. I., Rognum, T. O., Børresen-Dale, A.-L., & Gaudernack, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971219)74:6<664::aid-ijc18>3.0.co;2-5 · Cited by 181
Kim, Y. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2000.tb01863.x · Cited by 168
Association of K-ras mutations with p16 methylation in human colon cancer
Guan, R. J., Fu, Y., Holt, P. R., & Pardee, A. B. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70009-0 · Cited by 151
Shannon, B. A., Gnanasampanthan, S., Beilby, J., & Iacopetta, B. (2002) · Gut · doi:10.1136/gut.50.4.520 · Cited by 141
Self-citationWiencke, J. K., Zheng, S., Lafuente, A., Lafuente, M. J., Grudzen, C. R., Wrensch, M., Miike, R., Ballesta, A. M., & Trías, M. (1999) · PubMed · Cited by 132
Urea improves efficiency of bisulphite-mediated sequencing of 5'- methylcytosine in genomic DNA
Paulin, R., Grigg, G. W., Davey, M. W., & Piper, A. A. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.21.5009 · Cited by 130
Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma
Soong, R., Powell, B., Elsaleh, H., Gnanasampanthan, G., Smith, D. R., Goh, H. S., Joseph, D. J., & Iacopetta, B. M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00285-9 · Cited by 122
Self-citationTada, Y., Wada, M., Kuroiwa, K., Kinugawa, N., Harada, T., Nagayama, J., Nakagawa, M., Naito, S., & Kuwano, M. (2000) · PubMed · Cited by 117
Dietary intake and microsatellite instability in colon tumors
Slattery, M. L., Anderson, K. E., Curtin, K. P., Ma, K., Schaffer, D., & Samowitz, W. S. (2001) · International Journal of Cancer · doi:10.1002/ijc.1370 · Cited by 92
Liang, J., Chang, K., Chen, J., Lee, C.-C., Cheng, Y., Hsu, H., Wu, M., Wang, S., Lin, J., & Cheng, A. (1999) · Oncology · doi:10.1159/000012023 · Cited by 88
Malkhosyan, S. R., Yamamoto, H., Piao, Z. H., & Perucho, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.16154 · Cited by 78
Bian, Y.-S., Yan, P., Osterheld, M. C., Fontolliet, C., & Benhattar, J. (2001) · BioTechniques · doi:10.2144/01301st02 · Cited by 46
Gnanasampanthan, G., Elsaleh, H., McCaul, K. A., & Iacopetta, B. M. (2001) · The Journal of Pathology · doi:10.1002/path.990 · Cited by 37
Self-citation
Cited by
CpG island methylator phenotype in cancer
Issa, J.-P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1507 · Cited by 1,098
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Are there two sides to colorectal cancer?
Iacopetta, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10635 · Cited by 782
Self-citationOgino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M., Giovannucci, E. L., & Fuchs, C. S. (2009) · Gut · doi:10.1136/gut.2008.155473 · Cited by 777
Poor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon Cancers
Samowitz, W. S., Sweeney, C., Herrick, J., Albertsen, H., Levin, T. R., Murtaugh, M. A., Wolff, R. K., & Slattery, M. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0404 · Cited by 737
Metadata
- Authors
- van Rijnsoever, M., Grieu, F., Elsaleh, H., Joseph, D., & Iacopetta, B.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2002-12
- Volume
- 51
- Issue
- 6
- Pages
- 797-802
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2164467861
- Cited by
- 256
- References
- 39
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.